(function(){ var content_array=["

鍏充簬閾跺睉鐥呭拰鐗瑰簲鎬х毊鐐庯紙<\/b>AD<\/b>锛�<\/b><\/p> \n

閾跺睉鐥呮槸涓€绉嶅绯荤粺鐤剧梾锛岀壒寰佽〃鐜颁负杈圭晫娓呮鐨勭孩鏂戦碁灞戞€ф枒鍧楋紝甯哥槞鐥掋€傛垚浜轰腑閾跺睉鐥呮偅鐥呯巼鐨勪及璁″€艰寖鍥翠负0.51%-11.43%锛屽効绔ヤ腑涓�0%-1.37%[1]<\/sup>銆傞摱灞戠梾鏄竴绉嶅父瑙佺柧鐥咃紝闅忕潃骞撮緞鐨勫闀垮彂鐢熻緝澶氥€傛渶甯歌鐨勯摱灞戠梾涓村簥绫诲瀷鏄甯稿瀷閾跺睉鐥咃紙鏂戝潡鐘堕摱灞戠梾锛夈€傜値鐥囩粏鑳烇紙濡俆缁嗚優鍜岄珦鏍锋爲绐佺姸缁嗚優锛夊拰淇冪値缁嗚優鍥犲瓙锛堝鑲跨槫鍧忔鍥犲瓙-伪锛岀櫧缁嗚優浠嬬礌锛圛nterleukin, IL锛�-12鍜孖L-17锛夊湪閾跺睉鐥呭彂鐥呮満鍒朵腑鐨勫弬涓庡凡寰楀埌鍏呭垎璇佸疄[2]<\/sup>銆�<\/p> \n

鐩墠閾跺睉鐥呭皻鏃犳牴娌绘柟娉曘€傚甯稿瀷閾跺睉鐥呭彲閫氳繃灞€閮ㄦ不鐤椼€佸厜鐤楁垨鍏ㄨ韩娌荤枟鎴栧叾涓换浣曚竴绉嶈仈鍚堟不鐤楄繘琛岀鐞嗐€傜害80%鐨勬偅鑰呭嚭鐜拌交搴﹁嚦涓害鐤剧梾[3]<\/sup> [4]<\/sup>锛屽彲浠ユ帴鍙楀眬閮ㄦ不鐤椼€傜害涓夊垎涔嬩竴鐨勯摱灞戠梾鎮h€呭嚭鐜颁腑閲嶅害鐤剧梾锛屽叏韬€ц嵂鐗╋紙鐢熺墿瀛︽垨闈炵敓鐗╁锛夋垨鍏夌枟鏄腑閲嶅害閾跺睉鐥呯殑棣栭€夋柟妗�[5]<\/sup>銆傜劧鑰岋紝浣跨敤鐢熺墿鐤楁硶锛堜緥濡傛姉浣擄級闀挎湡娌荤枟閾跺睉鐥呭線寰€鍙楀埌瀹夊叏鎬у拰鑰愬彈鎬ч棶棰樼殑闄愬埗锛岄殢鐫€鏃堕棿鎺ㄧЩ鐤楁晥闄嶄綆锛岃€屼笖鐢变簬缁欒嵂閫斿緞涓嶄究锛堜緥濡傛敞灏勶級瀵艰嚧渚濅粠鎬ц緝宸�[6]<\/sup>銆傚洜姝わ紝灏氭湭婊¤冻涓噸搴﹂摱灞戠梾鎮h€呰繘琛屽畨鍏ㄣ€佹湁鏁堝拰鏂逛究鐨勯暱鏈熷彛鏈嶆不鐤楃殑闇€姹傘€�<\/p> \n

鐗瑰簲鎬х毊鐐庯紙Atopic Dermatitis, AD锛夋槸涓€绉嶄互婀跨柟鏍风毊鎹熷拰鍓х儓鐦欑棐涓虹壒寰佺殑鎱㈡€х値鐥囨€х柧鐥呫€傝鐥呯棁褰卞搷鍏ㄧ悆15%~30%鐨勫効绔ワ紝2%~10%鐨勬垚浜轰篃鍙兘鍙楀埌鍏跺奖鍝�[7]<\/sup>銆傝繖浜涚毊鑲ょ梾鍙樹腑鐨勭値鎬ф蹈娑﹀寘鎷琓娣嬪反缁嗚優銆佷腑鎬х矑缁嗚優銆佸棞閰告€х矑缁嗚優銆佸崟鏍哥粏鑳炪€佸法鍣粏鑳炲拰鑲ュぇ缁嗚優[8]<\/sup>銆傚湪杩欎簺鎮h€呯殑鐧界粏鑳炰腑涔熷彂鐜颁簡楂樻按骞砅DE4娲绘€�[9]<\/sup>銆侫D涓昏閲囩敤澶栫敤娌荤枟锛屼富瑕佹槸闂存瓏鎬ч闃叉€т娇鐢ㄥ鐢ㄧ毊璐ㄧ被鍥洪唶鍜孿/鎴栧鐢ㄩ挋璋冪7閰搁叾鎶戝埗鍓傦紝鍚屾椂姣忔棩浣跨敤娑﹁偆鍓傘€傞棿姝囨€т娇鐢ㄧ毊璐ㄧ被鍥洪唶寮曡捣鐨川绫诲浐閱囩浉鍏充笉鑹綔鐢紙濡傜毊鑲よ悗缂┿€佹晱鎰熸垨钖勭毊鍖哄煙褰㈡垚鏉$汗鍜屽叏韬晥搴旓級鐨勯闄╂瀬灏忋€傜劧鑰岋紝闀挎湡鍧氭寔澶栫敤娌荤枟鐨勬瘮鐜囪緝浣庛€傚湪鎴愪汉AD鎮h€呬腑锛岃秴璇存槑涔︿娇鐢ㄥ叾浠栧父瑙勫叏韬€у彛鏈嶅厤鐤皟鑺傚墏锛堝鐜绱犮€佺~鍞戝槍鍛ゅ拰鐢叉皑铦跺懁锛夊彲鑳芥湁鏁堬紝浣嗘偅鑰呭洜鎶ュ憡涓嶈壇浜嬩欢鎴栨棤鏁堝仠姝㈡不鐤楋紱浣跨敤杩欎簺鑽墿瀛樺湪宸茬煡鐨勫畨鍏ㄦ€у眬闄愭€э紝闇€瑕佸畾鏈熻繘琛屽疄楠屽鐩戞祴銆傚洜姝わ紝闇€瑕佹洿濂界殑鍏ㄨ韩鎬ф不鐤楅€夋嫨锛岀壒鍒槸瀵逛簬澶栫敤娌荤枟鐤楁晥涓嶄匠鐨凙D鎮h€呫€傚害鏅埄灏ゅ崟鎶楁槸涓€绉嶉澏鍚慖L-4鍜孖L-13鍙椾綋鐨勭毊涓嬫敞灏勭敓鐗╃枟娉曪紝缁忕編鍥介鍝佽嵂鍝佺洃鐫g鐞嗗眬鎵瑰噯鐢ㄤ簬娌荤枟涓害鑷抽噸搴D鎴愪汉鎮h€呫€傚湪杩欑鐤剧梾鐘舵€佷笅锛屽彛鏈嶆不鐤楅€夋嫨鐨勯渶姹備粛鐒舵槸褰撳姟涔嬫€ャ€�<\/p> \n

鍏�<\/b>浜�<\/b>Orismilast<\/b><\/p> \n

IBI353锛圤rismilast锛夋槸鐩墠姝e湪寮€鍙戠敤浜庨摱灞戠梾鍜岀毊鐐庡彛鏈嶆不鐤楃殑PDE4鎶戝埗鍓傘€侾DE4鏄竴绉嶇幆纾烽吀鑵鸿嫹锛圕yclic Adenosine Monophosphate, cAMP锛夌壒寮傛€DE锛岀敱鍏嶇柅鍜岀値鐥囩粏鑳炶〃杈撅紝鍖呮嫭T娣嬪反缁嗚優銆佷腑鎬х矑缁嗚優銆佸棞閰告€х矑缁嗚優銆佸崟鏍哥粏鑳炪€佹爲绐佺姸缁嗚優鍜屽法鍣粏鑳�[10]<\/sup>銆傚湪杩欎簺缁嗚優涓紝PDE4鏄富瑕佺殑PDE褰㈠紡锛孭DE4鎶戝埗鍓傚彲澧炲姞cAMP姘村钩銆傞珮cAMP姘村钩鍊惧悜浜庨檷浣庡娈栧拰缁嗚優鍥犲瓙鐢熸垚锛岃€屼綆娴撳害cAMP鍒欏叿鏈夌浉鍙嶇殑浣滅敤銆侾DE4鎶戝埗姝ゅ墠宸茬粡琚瘉鏄庝細涓嬭皟涓€绯诲垪淇冪値缁嗚優鍥犲瓙鐨勪骇鐢�[11]<\/sup>- <\/sup>[13]<\/sup>銆備笌浠ュ線鐮旂┒鍙戠幇涓€鑷达紝Orismilast灞曠幇鍑哄己鍔层€佸箍娉涚殑鎶楃値浣滅敤锛岄€氳繃鎶戝埗浜烘爲绐佺姸缁嗚優鐨勭粏鑳炲洜瀛愬垎娉岋紙TNF-伪銆両L-1尾鍜孖L-12锛夛紝骞朵笖鍦ㄤ綋澶栦篃璇佸疄浜嗗T缁嗚優娲诲寲鐨勬姂鍒朵綔鐢ㄣ€傜爺绌剁粨鏋滄敮鎸佽繘涓€姝ュ紑鍙憃rismilast锛屾湁鏈涙垚涓烘綔鍦ㄧ殑鍚岀被鏈€浣虫垨鍚岀被棣栧垱鐨凱DE4鎶戝埗鍓傦紝鐢ㄤ簬娌荤枟鎱㈡€х値鐥囨€х毊鑲ょ梾锛屽寘鎷摱灞戠梾銆丠S鍜孉D銆�<\/p> \n

鍏充簬淇¤揪鐢熺墿<\/b><\/p> \n

"濮嬩簬淇★紝杈句簬琛�"锛屽紑鍙戝嚭鑰佺櫨濮撶敤寰楄捣鐨勯珮璐ㄩ噺鐢熺墿鑽紝鏄俊杈剧敓鐗╃殑鐞嗘兂鍜岀洰鏍囥€備俊杈剧敓鐗╂垚绔嬩簬2011骞达紝鑷村姏浜庡紑鍙戙€佺敓浜у拰閿€鍞偪鐦ゃ€佷唬璋€€佽嚜韬厤鐤€佺溂绉戠瓑閲嶅ぇ鐤剧梾棰嗗煙鐨勫垱鏂拌嵂鐗┿€�2018骞�10鏈�31鏃ワ紝淇¤揪鐢熺墿鍒惰嵂鍦ㄩ娓仈鍚堜氦鏄撴墍鏈夐檺鍏徃涓绘澘涓婂競锛岃偂绁ㄤ唬鐮侊細01801銆�<\/p> \n

鑷垚绔嬩互鏉ワ紝鍏徃鍑€熷垱鏂版垚鏋滃拰鍥介檯鍖栫殑杩愯惀妯″紡鍦ㄤ紬澶氱敓鐗╁埗鑽叕鍙镐腑鑴遍鑰屽嚭銆傚缓绔嬭捣浜嗕竴鏉″寘鎷�35涓柊鑽搧绉嶇殑浜у搧閾撅紝瑕嗙洊鑲跨槫銆佽嚜韬厤鐤€佷唬璋€€佺溂绉戠瓑澶氫釜鐤剧梾棰嗗煙锛屽叾涓�7涓搧绉嶅叆閫夊浗瀹�"閲嶅ぇ鏂拌嵂鍒涘埗"涓撻」銆傚叕鍙稿凡鏈�8涓骇鍝侊紙淇¤开鍒╁崟鎶楁敞灏勬恫锛屽晢鍝佸悕锛氳揪浼垝®<\/sup>锛岃嫳鏂囧晢鏍囷細TYVYT®<\/sup>锛涜礉浼愮彔鍗曟姉鐢熺墿绫讳技鑽紝鍟嗗搧鍚嶏細杈炬敻鍚�®<\/sup>锛岃嫳鏂囧晢鏍囷細BYVASDA ®<\/sup>锛涢樋杈炬湪鍗曟姉鐢熺墿绫讳技鑽紝鍟嗗搧鍚嶏細鑻忕珛淇�®<\/sup>锛岃嫳鏂囧晢鏍囷細SULINNO ®<\/sup>锛涘埄濡ユ様鍗曟姉鐢熺墿绫讳技鑽紝鍟嗗搧鍚嶏細杈句集鍗�®<\/sup>锛岃嫳鏂囧晢鏍囷細HALPRYZA®<\/sup>锛涗僵绫虫浛灏肩墖锛屽晢鍝佸悕锛氳揪浼潶®锛岃嫳鏂囧晢鏍囷細PEMAZYRE®<\/sup>锛涘ゥ闆峰反鏇垮凹鐗囷紝鍟嗗搧鍚嶏細鑰愮珛鍏�®<\/sup>锛涢浄鑾タ灏ゅ崟鎶楋紝鍟嗗搧鍚嶏細甯屽唹鎷�®<\/sup>锛岃嫳鏂囧晢鏍囷細CYRAMZA®<\/sup>锛涘鏅浛灏艰兌鍥婏級鑾峰緱鎵瑰噯涓婂競锛�2涓搧绉嶅湪NMPA瀹¤瘎涓紝5涓柊鑽垎瀛愯繘鍏II鏈熸垨鍏抽敭鎬т复搴婄爺绌讹紝鍙﹀杩樻湁20涓柊鑽搧绉嶅凡杩涘叆涓村簥鐮旂┒銆�<\/p> \n

淇¤揪鐢熺墿宸茬粍寤轰簡涓€鏀叿鏈夊浗闄呭厛杩涙按骞崇殑楂樼鐢熺墿鑽紑鍙戙€佷骇涓氬寲浜烘墠鍥㈤槦锛屽寘鎷紬澶氭捣褰掍笓瀹讹紝骞朵笌缇庡浗绀兼潵鍒惰嵂銆佽禌璇鸿彶銆丄dimab銆両ncyte銆丮D Anderson 鐧岀棁涓績绛夊浗闄呭悎浣滄柟杈炬垚鎴樼暐鍚堜綔銆備俊杈剧敓鐗╁笇鏈涘拰澶у涓€璧峰姫鍔涳紝鎻愰珮涓浗鐢熺墿鍒惰嵂浜т笟鐨勫彂灞曟按骞筹紝浠ユ弧瓒崇櫨濮撶敤鑽彲鍙婃€у拰浜烘皯瀵圭敓鍛藉仴搴风編濂芥効鏈涚殑杩芥眰銆�<\/p> \n

璇︽儏璇疯闂叕鍙哥綉绔欙細www.innoventbio.com<\/a>鎴栧叕鍙搁鑻辫处鍙凤細Innovent Biologics銆�<\/p> \n

鍏充簬<\/b>UNION therapeutics<\/b><\/p> \n

UNION therapeutics鏄竴瀹朵笓娉ㄤ簬鍏嶇柅瀛﹀拰浼犳煋鐥呫€佹嫢鏈夊涓复搴婇樁娈电绾跨殑闈炰笂甯傚埗鑽叕鍙搞€傚叕鍙哥洰鍓嶄富鏀讳袱澶т簰琛ョ殑鍖栧鏂瑰悜锛岃鐩栧厤鐤鍜屽井鐢熺墿瀛︼紝鐩墠鏈変竷涓」鐩浜庝复搴婂紑鍙戦樁娈点€俇NION鍏徃鎬婚儴浣嶄簬涓归害娴峰嫆椴佹櫘 (Hellerup)锛岄珮绠″洟闃熸嫢鏈夌敓鐗╂妧鏈叕鍙稿垱涓氱粡楠屽拰璺ㄥ浗鑽紒楂樺眰绠$悊缁忛獙锛屾€昏鏇句富瀵艰秴杩�15涓骇鍝佺殑鏂拌嵂鑾锋壒銆傝鎯呰璁块棶鍏徃缃戠珯锛� www.uniontherapeutics.com<\/a><\/p> \n

澹版槑锛�<\/i><\/p> \n

1. 璇ラ€傚簲鐥囦负鐮旂┒涓殑鑽搧鐢ㄦ硶锛屽皻鏈湪涓浗鑾锋壒锛�<\/i><\/p> \n

2. 淇¤揪涓嶆帹鑽愪换浣曟湭鑾锋壒鐨勮嵂鍝乗/閫傚簲鐥囦娇鐢ㄣ€�<\/i><\/p> \n

淇¤揪鐢熺墿鍓嶇灮鎬у0鏄�<\/b><\/p> \n

鏈柊闂荤ǹ鎵€鍙戝竷鐨勪俊鎭腑鍙兘浼氬寘鍚煇浜涘墠鐬绘€ц〃杩般€傝繖浜涜〃杩版湰璐ㄤ笂鍏锋湁鐩稿綋椋庨櫓鍜屼笉纭畾鎬с€傚湪浣跨敤"棰勬湡"銆�"鐩镐俊"銆�"棰勬祴"銆�"鏈熸湜"銆�"鎵撶畻"鍙婂叾浠栫被浼艰瘝璇繘琛岃〃杩版椂锛屽嚒涓庢湰鍏徃鏈夊叧鐨勶紝鐩殑鍧囨槸瑕佹寚鏄庡叾灞炲墠鐬绘€ц〃杩般€傛湰鍏徃骞舵棤涔夊姟涓嶆柇鍦版洿鏂拌繖浜涢娴嬫€ч檲杩般€�<\/p> \n

杩欎簺鍓嶇灮鎬ц〃杩颁箖鍩轰簬鏈叕鍙哥鐞嗗眰鍦ㄥ仛鍑鸿〃杩版椂瀵规湭鏉ヤ簨鍔$殑鐜版湁鐪嬫硶銆佸亣璁俱€佹湡鏈涖€佷及璁°€侀娴嬪拰鐞嗚В銆傝繖浜涜〃杩板苟闈炲鏈潵鍙戝睍鐨勪繚璇侊紝浼氬彈鍒伴闄┿€佷笉纭€у強鍏朵粬鍥犵礌鐨勫奖鍝嶏紝鏈変簺涔冭秴鍑烘湰鍏徃鐨勬帶鍒惰寖鍥达紝闅句互棰勮銆傚洜姝わ紝鍙楁垜浠殑涓氬姟銆佺珵浜夌幆澧冦€佹斂娌汇€佺粡娴庛€佹硶寰嬪拰绀句細鎯呭喌鐨勬湭鏉ュ彉鍖栧強鍙戝睍鐨勫奖鍝嶏紝瀹為檯缁撴灉鍙兘浼氫笌鍓嶇灮鎬ц〃杩版墍鍚祫鏂欐湁杈冨ぇ宸埆銆�<\/p> \n

鏈叕鍙搞€佹湰鍏徃钁d簨鍙婇泧鍛樹唬鐞嗘涓嶆壙鎷� (a) 鏇存鎴栨洿鏂版湰缃戠珯鎵€杞藉墠鐬绘€ц〃杩扮殑浠讳綍涔夊姟;鍙� (b) 鑻ュ洜浠讳綍鍓嶇灮鎬ц〃杩颁笉鑳藉疄鐜版垨鍙樻垚涓嶆纭€屽紩鑷寸殑浠讳綍璐d换銆�<\/p> \n

鍙傝€冩枃鐚細<\/p> \n

[1].   Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212. doi: 10.1111\/jdv.13854. Epub 2016 Aug 30.<\/p> \n

[2].   Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, Buffa E, et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology. 2011;223(1):57-67.<\/p> \n

[3].   Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-9<\/p> \n

[4].   Menter A, Korman NJ, Elmets C, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009;61:451-85.<\/p> \n

[5].   Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the management and treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62:114-135.<\/p> \n

[6].   Ravindran V, Scott DL, Choy EH. A systemic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis. 2008;67:855-859.<\/p> \n

[7].   Bieber T. Mechanism of disease. Atopic dermatitis. N Engl J Med 2008 358: 1483-94.<\/p> \n

[8].   Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994, 102:128鈥�137.<\/p> \n

[9].   Butler JM, Chan SC, Stevens S, Hanifin JM: Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol 1983, 71:490鈥�497.<\/p> \n

[10].    Spina D. PDE4 inhibitors: current status. Br J Pharmacol. 2008;155(3):308-315.<\/p> \n

[11].    Brideau C, Van Staden<\/span> C, Styhler A, Rodger IW, Chan C-C. The effects of phosphodiesterase type鈥�4 inhibitors on tumour necrosis factor-伪 and leukotriene B4 in a novel human whole blood assay. Br J Pharmacol 1999;126(4):979-88.<\/p> \n

[12].    Manning CD, Burman M, Christensen SB, Cieslinski LB, Essayan DM, Grous M, et al. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B. Br J Pharmacol 1999;128(7):1393-8.<\/p> \n

[13].    Samrao A, Berry TM, Goreshi R, Simpson EL. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol 2012;148(8):890-7.<\/p>"]; $("#dvExtra").html(content_array[0]);})();